IMC Chicago LLC Takes Position in VanEck Pharmaceutical ETF $PPH

IMC Chicago LLC acquired a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,549 shares of the company’s stock, valued at approximately $1,707,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. IFP Advisors Inc lifted its position in shares of VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after acquiring an additional 153 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of VanEck Pharmaceutical ETF in the third quarter valued at $41,000. CWM LLC lifted its position in shares of VanEck Pharmaceutical ETF by 36.3% in the fourth quarter. CWM LLC now owns 511 shares of the company’s stock valued at $53,000 after acquiring an additional 136 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of VanEck Pharmaceutical ETF by 64.7% in the fourth quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock valued at $74,000 after acquiring an additional 282 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in shares of VanEck Pharmaceutical ETF by 305.6% in the third quarter. PNC Financial Services Group Inc. now owns 1,014 shares of the company’s stock valued at $92,000 after acquiring an additional 764 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ PPH opened at $102.32 on Monday. The business’s 50-day moving average price is $104.37 and its 200 day moving average price is $102.66. VanEck Pharmaceutical ETF has a twelve month low of $81.74 and a twelve month high of $112.58. The company has a market capitalization of $971.02 million, a PE ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Investors of record on Wednesday, April 1st were given a dividend of $0.8441 per share. This represents a $3.38 annualized dividend and a yield of 3.3%. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. The ex-dividend date was Wednesday, April 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.